72 related articles for article (PubMed ID: 1694021)
1. Biochemical assessment and prediction of gestational well-being.
Martin JN; Cowan BD
Obstet Gynecol Clin North Am; 1990 Mar; 17(1):81-93. PubMed ID: 1694021
[TBL] [Abstract][Full Text] [Related]
2. Endocrine assessments of fetal-placental well-being.
Tulchinsky D
Clin Perinatol; 1983 Oct; 10(3):763-76. PubMed ID: 6197223
[TBL] [Abstract][Full Text] [Related]
3. [Clinical use of a quadruple biochemical marker in the prediction of obstetric complications].
Aranda Gallegos JE; Barrón Vallejo J; de la Luna Pérez LG; Corona de Lau QC; Kably Ambe A
Ginecol Obstet Mex; 1999 Jan; 67():18-22. PubMed ID: 10085605
[TBL] [Abstract][Full Text] [Related]
4. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
5. [Serum screening of pregnant women reveals Down syndrome. Analysis of biochemical markers for earlier detection].
Christiansen M; Larsen SO; Nørgaard-Pedersen B
Lakartidningen; 1997 Dec; 94(51-52):4898-902. PubMed ID: 9454010
[TBL] [Abstract][Full Text] [Related]
6. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
8. Contemporary approaches to prenatal diagnosis.
Kuller JA; Laifer SA
Am Fam Physician; 1995 Dec; 52(8):2277-83, 2285-6. PubMed ID: 7484721
[TBL] [Abstract][Full Text] [Related]
9. Prenatal screening for trisomy 18.
Reynolds TM; Wierzbicki A
Prenat Diagn; 1996 May; 16(5):475-6; author reply 477-8. PubMed ID: 8844010
[No Abstract] [Full Text] [Related]
10. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
[TBL] [Abstract][Full Text] [Related]
11. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC
Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058
[TBL] [Abstract][Full Text] [Related]
12. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
Dick PT
CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
[TBL] [Abstract][Full Text] [Related]
13. Quad screen as a predictor of adverse pregnancy outcome.
Dugoff L; Hobbins JC; Malone FD; Vidaver J; Sullivan L; Canick JA; Lambert-Messerlian GM; Porter TF; Luthy DA; Comstock CH; Saade G; Eddleman K; Merkatz IR; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
[TBL] [Abstract][Full Text] [Related]
14. Multiple marker screening for Down syndrome in twin pregnancies.
Neveux LM; Palomaki GE; Knight GJ; Haddow JE
Prenat Diagn; 1996 Jan; 16(1):29-34. PubMed ID: 8821849
[TBL] [Abstract][Full Text] [Related]
15. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
[TBL] [Abstract][Full Text] [Related]
16. Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption.
Tikkanen M; Hämäläinen E; Nuutila M; Paavonen J; Ylikorkala O; Hiilesmaa V
Prenat Diagn; 2007 Mar; 27(3):240-3. PubMed ID: 17238224
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
MacDonald ML; Wagner RM; Slotnick RN
Obstet Gynecol; 1991 Jan; 77(1):63-8. PubMed ID: 1701526
[TBL] [Abstract][Full Text] [Related]
18. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
Rose NC; Mennuti MT
West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
[TBL] [Abstract][Full Text] [Related]
20. Endocrine assays in the monitoring of pregnancy.
Rock RC; Chan DW; Perlstein MT
Clin Lab Med; 1981 Jun; 1(2):157-79. PubMed ID: 6286209
[No Abstract] [Full Text] [Related]
[Next] [New Search]